17-3818496-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001114118.3(NCBP3):āc.1077A>Cā(p.Glu359Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001114118.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCBP3 | NM_001114118.3 | c.1077A>C | p.Glu359Asp | missense_variant | 10/13 | ENST00000389005.6 | NP_001107590.1 | |
NCBP3 | NM_001398494.1 | c.1077A>C | p.Glu359Asp | missense_variant | 10/14 | NP_001385423.1 | ||
NCBP3 | XR_007065313.1 | n.1100A>C | non_coding_transcript_exon_variant | 10/15 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250914Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135614
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461250Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726954
GnomAD4 genome AF: 0.000197 AC: 30AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 07, 2024 | The c.1077A>C (p.E359D) alteration is located in exon 10 (coding exon 10) of the NCBP3 gene. This alteration results from a A to C substitution at nucleotide position 1077, causing the glutamic acid (E) at amino acid position 359 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at